Hangzhou, China

Dongxiang Feng

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2020-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Inventor Dongxiang Feng: A Pioneer in Pharmaceutical Innovations**

Introduction

Dongxiang Feng, an innovative inventor based in Hangzhou, CN, has made significant strides in the field of medicine through his inventive processes. With a total of two patents to his name, Feng's contributions are notable for their potential applications in pharmaceutical development.

Latest Patents

Feng's latest patents include groundbreaking processes for preparing two important pharmaceutical compounds. The first patent details a method for synthesizing 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indanacetonitrile. This inventive process is characterized by a one-pot reaction that simplifies the synthetic route and enhances the yield of the target compound. In this process, the inventor combines 6-fluoro-2-methyl-1-indanone, cyanoacetic acid, a first organic solvent, and an acetic acid-based catalyst to achieve a first condensation reaction, ultimately leading to the desired compound without the need for intermediate separation.

The second patent focuses on the method for preparing levobunolol hydrochloride, a vital pharmaceutical compound. This innovative method involves a substitution reaction using S-1-tert-butyl-epoxy methylamine and 5-hydroxy-1-tetralone, followed by acidification to yield levobunolol hydrochloride with impressive regioselectivity. The process boasts a yield of 87.3% and an enantiomeric excess (ee) greater than 99%, showcasing Feng's ability to improve both the efficiency and purity of pharmaceutical compounds.

Career Highlights

Dongxiang Feng has been associated with notable institutions such as Hangzhou Normal University and Hangzhou Loop Biotech Co., Ltd. His work in these organizations has contributed to advancements in research and development within the pharmaceutical industry.

Collaborations

Throughout his career, Feng has collaborated with esteemed colleagues, including Weiming Xu and Lianzhi Tao. These partnerships have likely played a significant role in his research endeavors and innovation processes.

Conclusion

Dongxiang Feng stands out as an inspiring figure in pharmaceutical innovations. His inventive processes have not only enhanced the synthetic efficiency of important compounds but also contribute to the broader field of medicine. With his continued efforts and collaborations, Feng is set to leave a lasting impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…